Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9825
0.00 (0.00%)
At close: Jul 2, 2026, 4:00 PM EDT
0.9800
-0.0025 (-0.25%)
After-hours: Jul 2, 2026, 6:59 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $42.28 million as of July 2, 2026. Its market cap has increased by 29.90% in one year.
Market Cap
42.28M
Enterprise Value
40.35M
1-Year Change
29.90%
Ranking
Category
Stock Price
$0.98
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $42.28M, an increase of 2,278.55%. That is a compound annual growth rate of 135.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 42.28M | -28.23% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 48.02M |
| PDS Biotechnology | 47.62M |
| Metagenomi Therapeutics | 47.44M |
| Hyperion DeFi | 47.14M |
| ABVC BioPharma | 45.49M |
| INmune Bio | 45.19M |
| Apollomics | 42.95M |
| RenovoRx | 41.50M |